COLLAGENASE LOADED LIPOSOMES FOR ENHANCING DRUG DELIVERY

Avi Schroeder; Assaf Zinger

COLLAGENASE LOADED LIPOSOMES FOR ENHANCING DRUG DELIVERY

Avi Schroeder (Inventor), Assaf Zinger (Inventor)

Chemical Engineering

Technion - Israel Institute of Technology

Research output: Patent

Abstract

Pharmaceutical compositions comprising at least one lipid-based particle encapsulating a proteolytic enzyme and a pharmaceutically acceptable carrier, wherein the proteolytic enzyme comprises at least 75% proteolytically active enzyme are provided. Methods of using same and producing same are also provided.

Original language	American English
Patent number	WO2019145950
IPC	A61K 9/ 127 A I
Priority date	23/01/18
State	Published - 1 Aug 2019

Cite this

@misc{a9e041c95f4346028fcabfb06db1cb03,

title = "COLLAGENASE LOADED LIPOSOMES FOR ENHANCING DRUG DELIVERY",

abstract = "Pharmaceutical compositions comprising at least one lipid-based particle encapsulating a proteolytic enzyme and a pharmaceutically acceptable carrier, wherein the proteolytic enzyme comprises at least 75% proteolytically active enzyme are provided. Methods of using same and producing same are also provided.",

author = "Avi Schroeder and Assaf Zinger",

year = "2019",

month = aug,

day = "1",

language = "American English",

type = "Patent",

note = "WO2019145950; A61K 9/ 127 A I",

}

TY - PAT

T1 - COLLAGENASE LOADED LIPOSOMES FOR ENHANCING DRUG DELIVERY

AU - Schroeder, Avi

AU - Zinger, Assaf

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Pharmaceutical compositions comprising at least one lipid-based particle encapsulating a proteolytic enzyme and a pharmaceutically acceptable carrier, wherein the proteolytic enzyme comprises at least 75% proteolytically active enzyme are provided. Methods of using same and producing same are also provided.

AB - Pharmaceutical compositions comprising at least one lipid-based particle encapsulating a proteolytic enzyme and a pharmaceutically acceptable carrier, wherein the proteolytic enzyme comprises at least 75% proteolytically active enzyme are provided. Methods of using same and producing same are also provided.

M3 - Patent

M1 - WO2019145950

ER -